Activation of the mTOR signaling pathway by L-leucine in 5q-syndrome and other RPS14-deficient erythroblasts

B. H. Yip, C. Vuppusetty, M. Attwood, A. Giagounidis, U. Germing, A. A. Lamikanra, D. J. Roberts, J. P. MacIejewski, P. Vandenberghe, C. Mecucci, J. S. Wainscoat, A. Pellagatti, J. Boultwood

Research output: Contribution to journalLetterpeer-review

7 Citations (Scopus)
Original languageEnglish
Pages (from-to)1760-1763
Number of pages4
Issue number8
Publication statusPublished - Aug 2013
Externally publishedYes

Bibliographical note

Funding Information:
This work was supported by Leukaemia and Lymphoma Research of the United Kingdom and in part by the National Institute for Health Research (NIHR) and by the Blood Theme in the NIHR Oxford Biomedical Research Centre, Oxford University Hospitals Trust. PV is a senior clinical investigator of FWO-Vlaanderen.

Cite this